Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × liposomal doxorubicin × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 11 Fallopian Tube Neoplasms 7 Breast Neoplasms 5 Triple Negative Breast Neoplasms 3 Sarcoma, Kaposi 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Carcinoma, Ovarian Epithelial 2 Acquired Immunodeficiency Syndrome 2 Vaccinia 1 Sarcoma, Ewing 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Follicular 1 Lymphoma 1 Lymphadenopathy 1 Low Grade Serous Ovarian Cancer 1 Leiomyosarcoma 1 Hodgkin Disease 1 HIV Infections 1 AIDS-related Kaposi sarcoma 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡